Kaiser: 73% of brokers dislike PPACA; 20% like itNews added by National Underwriter on June 18, 2012
National Underwriter

National Underwriter

Joined: April 22, 2011

By Allison Bell

A few U.S. health insurance brokers say the Patient Protection and Affordable Care Act of 2010 (PPACA) will help the United States as a whole.

But most brokers think PPACA will hurt their businesses, and even more think PPACA will hurt other brokers' businesses.

Analysts at the Henry J. Kaiser Family Foundation, Menlo Park, Calif., has reported that finding in a summary of results from a telephone survey of 500 brokers that was conducted in February and March.

About 80% of the brokers polled were in companies with 9 or fewer employees.

The Kaiser analysts found that the brokers polled tended to take a dim view of PPACA, and that, the closer the questions focused on the health insurance brokerage business, the more negatives the views expressed were.

Brokers say a PPACA minimum medical loss ratio (MLR) provision that requires health insurers to spend 85% of large group revenue and 80% of individual and small group revenue on health care and qualtiy improvement efforts is giving insurers an excuse to cut commissions.

About 20% of the brokers said they had a favorable opinion about PPACA, with 11% saying they had a somewhat favorable opinion about PPACA and 9% saying they had a very favorable opinion. The percentage of members of the general public who say they like the law is 41%, the analysts say.

When brokers talked about the effects of PPACA, 14% said it would help the country as a whole, 8% said it would have little effect, and 72% said it would hurt the country.

About 6% of the brokers said they think PPACA will help their own businesses, and 22% said the law will have little effect on their businesses.

Originally published on LifeHealthPro.com
The views expressed here are those of the author and not necessarily those of ProducersWEB.
Reprinting or reposting this article without prior consent of Producersweb.com is strictly prohibited.
If you have questions, please visit our terms and conditions
Post Press Release